Literature DB >> 28069857

Market Share Matters: Evidence Of Insurer And Provider Bargaining Over Prices.

Eric T Roberts1, Michael E Chernew2, J Michael McWilliams3.   

Abstract

Proposed mergers among large US health insurers and growing consolidation among providers have renewed concerns about the effects of market concentration on commercial health care prices. Using multipayer claims for physician services provided in office settings, we estimated that-within the same provider groups-insurers with market shares of 15 percent or more (average: 24.5 percent), for example, negotiated prices for office visits that were 21 percent lower than prices negotiated by insurers with shares of less than 5 percent. Analyses stratified by provider market share suggested that insurers require greater market shares to negotiate lower prices from large provider groups than they do when negotiating with smaller provider groups. For example, office visit prices for small practices were $88, $72, and $70, for insurers with market shares of <5 percent, ≥5 to <15 percent, and ≥15 percent, respectively, whereas prices for large provider groups were $97, $86, and $76, exhibiting a continued decrease across higher insurer-market-share categories. These results suggest that mergers of health insurers could lower the prices paid to providers, particularly providers large enough to obtain higher prices from insurers with modest market shares. Continued monitoring will be important for determining the net effects of the countervailing trends of insurer and provider consolidation on the affordability of health care. Project HOPE—The People-to-People Health Foundation, Inc.

Keywords:  Cost of Health Care; Health Economics; Health Spending

Mesh:

Year:  2017        PMID: 28069857     DOI: 10.1377/hlthaff.2016.0479

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  7 in total

1.  Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging Issues.

Authors:  Patricia M Danzon
Journal:  Pharmacoeconomics       Date:  2018-12       Impact factor: 4.981

2.  Competition and health plan quality in the Medicare Advantage market.

Authors:  Emily R Adrion
Journal:  Health Serv Res       Date:  2019-08-05       Impact factor: 3.402

3.  Transformation of the Health Care Industry: Curb Your Enthusiasm?

Authors:  Lawton R Burns; Mark V Pauly
Journal:  Milbank Q       Date:  2018-03       Impact factor: 4.911

4.  Prices for physician services in Medicare Advantage versus traditional Medicare.

Authors:  Julius L Chen; Andrew L Hicks; Michael E Chernew
Journal:  Am J Manag Care       Date:  2018-07       Impact factor: 2.229

5.  Prices and market power in mental health care: Evidence from a major policy change in the Netherlands.

Authors:  Chiara Brouns; Rudy Douven; Ron Kemp
Journal:  Health Econ       Date:  2021-01-27       Impact factor: 3.046

6.  Health system integration with physician specialties varies across markets and system types.

Authors:  Rachel M Machta; James D Reschovsky; David J Jones; Laura Kimmey; Michael F Furukawa; Eugene C Rich
Journal:  Health Serv Res       Date:  2020-12       Impact factor: 3.402

7.  Financial risk allocation and provider incentives in hospital-insurer contracts in The Netherlands.

Authors:  Chandeni S Gajadien; Peter J G Dohmen; Frank Eijkenaar; Frederik T Schut; Erik M van Raaij; Richard Heijink
Journal:  Eur J Health Econ       Date:  2022-04-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.